- Home
- IPW vs TXMD Comparison
IPW vs TXMD Comparison
Compare IPW & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- TXMD
- Stock Information
- Founded
- IPW 2018
- TXMD 2008
- Country
- IPW United States
- TXMD United States
- Employees
- IPW N/A
- TXMD N/A
- Industry
- IPW Catalog/Specialty Distribution
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- IPW Consumer Discretionary
- TXMD Health Care
- Exchange
- IPW Nasdaq
- TXMD Nasdaq
- Market Cap
- IPW 14.4M
- TXMD 13.9M
- IPO Year
- IPW 2021
- TXMD N/A
- Fundamental
- Price
- IPW $0.66
- TXMD $1.19
- Analyst Decision
- IPW
- TXMD
- Analyst Count
- IPW 0
- TXMD 0
- Target Price
- IPW N/A
- TXMD N/A
- AVG Volume (30 Days)
- IPW 189.7K
- TXMD 30.8K
- Earning Date
- IPW 09-18-2025
- TXMD 07-30-2025
- Dividend Yield
- IPW N/A
- TXMD N/A
- EPS Growth
- IPW N/A
- TXMD N/A
- EPS
- IPW N/A
- TXMD N/A
- Revenue
- IPW $74,105,251.00
- TXMD $1,841,000.00
- Revenue This Year
- IPW $8.31
- TXMD $427.09
- Revenue Next Year
- IPW $77.15
- TXMD N/A
- P/E Ratio
- IPW N/A
- TXMD N/A
- Revenue Growth
- IPW N/A
- TXMD 53.55
- 52 Week Low
- IPW $0.41
- TXMD $0.70
- 52 Week High
- IPW $2.36
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- IPW 51.56
- TXMD 51.94
- Support Level
- IPW $0.61
- TXMD $1.12
- Resistance Level
- IPW $0.72
- TXMD $1.24
- Average True Range (ATR)
- IPW 0.05
- TXMD 0.06
- MACD
- IPW -0.01
- TXMD 0.01
- Stochastic Oscillator
- IPW 28.31
- TXMD 70.59
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.